全文获取类型
收费全文 | 12120篇 |
免费 | 1053篇 |
国内免费 | 253篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 301篇 |
妇产科学 | 220篇 |
基础医学 | 1380篇 |
口腔科学 | 183篇 |
临床医学 | 1953篇 |
内科学 | 1352篇 |
皮肤病学 | 148篇 |
神经病学 | 906篇 |
特种医学 | 193篇 |
外国民族医学 | 3篇 |
外科学 | 604篇 |
综合类 | 1671篇 |
一般理论 | 2篇 |
预防医学 | 2182篇 |
眼科学 | 73篇 |
药学 | 1004篇 |
14篇 | |
中国医学 | 612篇 |
肿瘤学 | 575篇 |
出版年
2024年 | 8篇 |
2023年 | 236篇 |
2022年 | 287篇 |
2021年 | 515篇 |
2020年 | 557篇 |
2019年 | 472篇 |
2018年 | 444篇 |
2017年 | 500篇 |
2016年 | 512篇 |
2015年 | 479篇 |
2014年 | 1018篇 |
2013年 | 1081篇 |
2012年 | 743篇 |
2011年 | 846篇 |
2010年 | 640篇 |
2009年 | 536篇 |
2008年 | 557篇 |
2007年 | 533篇 |
2006年 | 454篇 |
2005年 | 379篇 |
2004年 | 326篇 |
2003年 | 271篇 |
2002年 | 222篇 |
2001年 | 203篇 |
2000年 | 182篇 |
1999年 | 161篇 |
1998年 | 94篇 |
1997年 | 118篇 |
1996年 | 103篇 |
1995年 | 108篇 |
1994年 | 97篇 |
1993年 | 71篇 |
1992年 | 76篇 |
1991年 | 76篇 |
1990年 | 59篇 |
1989年 | 54篇 |
1988年 | 38篇 |
1987年 | 44篇 |
1986年 | 31篇 |
1985年 | 61篇 |
1984年 | 39篇 |
1983年 | 34篇 |
1982年 | 36篇 |
1981年 | 17篇 |
1980年 | 25篇 |
1979年 | 20篇 |
1978年 | 14篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
3.
Tian-Chi Tsai Huan-Ka Chiung Liang-Hsuan Chen Hsien-Ming Wu 《Taiwanese journal of obstetrics & gynecology》2021,60(3):567-569
ObjectiveAssisted oocyte activation combined with ICSI (ICSI-AOA) has been reported to improve fertilization outcomes of couples with oocyte activation deficiency (OAD). Although there's no sufficient evidence to support ICSI-AOA as routine use, it might be beneficial for POSEIDON group 3 patients with suspected oocyte-related OAD.Case reportA 29-year-old female presented with a history of primary infertility for two years. She was classified as a POSEIDON group 3 patient and had a total fertilization failure history. With the help of ICSI-AOA, six oocytes were successfully fertilized. Pregnancy was later confirmed after embryo transfer. A living infant was born after 34 weeks of pregnancy.ConclusionOAD should be taken into consideration for POSEIDON group 3 patients since low Antimüllerian hormone is associated decreased quality. Further research needs to be done to understand the mechanism underlying oocyte-related OAD and the potential role of ICSI-AOA in young patients with suboptimal ovarian response. 相似文献
4.
5.
《Vaccine》2021,39(33):4742-4750
Allogeneic hematopoietic stem cell transplantation (alloHSCT) results in a loss of humoral immunity and subsequent risk for severe infections. Thus, re-vaccination is required but may fail due to incomplete immune reconstitution. We retrospectively analyzed predictors of immune response to primary vaccination applied according to the EBMT (European Blood and Marrow Transplantation Group) recommendations. Serologic response to vaccination against diphtheria (D), tetanus (T), Bordetella pertussis (aP) and Haemophilus influenzae (Hib) (administrated as combined DTaP-Hib-IPV vaccination) was studied in 84 alloHSCT patients transplanted between 2008 and 2015 (age at alloHSCT: 18.6–70.6 years). All patients with a relapse-free survival of ≥9 months, at least 3 consecutive vaccinations and absence of intravenous immunoglobulin administration within 3 months before and after vaccination met the primary inclusion criteria. Additionally, immunological response to a pneumococcal conjugate vaccine was analyzed in a subgroup of 67 patients. Patients’ characteristics at the time of first vaccination were recorded. Responses were measured as vaccine-specific antibody titers. Regarding DTaP-Hib-IPV vaccination, 89.3% (n = 75) of all patients achieved protective titers to at least 3 of the 4 vaccine components and were thus considered responders. 10.7% (n = 9) of the patients were classified as non-responders with positive immune response to less than 3 components. Highest response was observed for Hib (97.4%), tetanus (95.2%) and pneumococcal vaccination (83.6%) while only 68.3% responded to vaccination against Bordetella pertussis. Significant risk factors for failure of vaccination response included low B cell counts (p < 0.001; cut-off: 0.05 B cells/nl) and low IgG levels (p = 0.026; mean IgG of responders 816 mg/dl vs. 475 mg/dl of non-responders). Further, a trend was observed that prior cGvHD impairs vaccination response as 88.9% of the non-responders but only 54.7% of the responders had prior cGvHD (p = 0.073). The results demonstrate, that the currently proposed vaccination strategy leads to seroprotection in the majority of alloHSCT patients. 相似文献
6.
《Vaccine》2021,39(15):2146-2152
Countries face an increasingly complex vaccination landscape. As well as ever-changing infectious disease epidemiology, the number and diversity of vaccine-preventable diseases, vaccine products, and vaccine technologies continue to increase. To ensure that vaccination decision-making is transparent, country-owned and informed by sound scientific evidence, many countries have established national immunization technical advisory groups (NITAGs) to provide independent expert advice. The past decade has seen substantial growth in NITAG numbers and functionality, and there is now a need to consolidate this progress, by further capacity building, to ensure that NITAGs are responsive to the changing face of immunization over the next decade. 相似文献
7.
Kazuya Inoue Naoki Suenaga Naomi Oizumi Hiroshi Yamaguchi Naoki Miyoshi Noboru Taniguchi Noriaki Matsumura Shuzo Morita Shimpei Kurata Yasuhito Tanaka 《Seminars in Arthroplasty》2022,32(2):252-257
BackgroundIn shoulder arthroplasty, bone resorption around the stem can lead to stem loosening and makes surgery difficult at the time of revision. Proximal bone resorption after reverse shoulder arthroplasty can cause instability because of a decrease of deltoid wrapping effect. As factors of the stem itself, such as stem coating, shape, length, and use of bone cement, may also affect bone resorption, a single-stem model should be used to compare bone resorptions between different pathologies and surgical procedures. However, to date, a few reports have compared these differences in detail using a single-stem model. Therefore, we investigated the prevalence and location of humeral bone resorption in a single-stem model.MethodsThe study included 100 shoulders that underwent anatomical total shoulder arthroplasty (TSA) or humeral head replacement (HHR) with a single uncemented humeral stem from 2008 to 2018. The patients were 31 men and 69 women. The mean age at surgery was 72.9 years (range, 41-86 years). The patients were divided into three groups: especially, 25, 61, and 14 shoulders received TSA for primary osteoarthritis without rotator cuff tears (TSA group), HHR using an anatomical head with rotator cuff repair for cuff tear arthropathy (CTA) (HHR group), and HHR using a CTA head without rotator cuff repair (CTA group), respectively. Patients were monitored for a mean of 56 months (range, 12-98 months). The location of bone resorption was divided into seven zones as follows: zone 1, greater tuberosity; zone 2, lateral diaphysis; zone 3, lateral diaphysis beyond the deltoid tuberosity; zone 4, tip of the stem; zone 5, medial diaphysis beyond the deltoid tuberosity; zone 6, medial diaphysis; and zone 7, calcar region. The degree of bone resorption was classified from grade 0 to 4.ResultsBone resorption of grade 3 or higher was significantly more frequent at the greater tuberosity in the HHR and CTA groups (P < .001 and P < .001, respectively) than that in the TSA group. Grade 4 bone resorption was significantly more frequent in the CTA than that in the TSA and HHR groups in zone 1 (P = .016 and P = .041, respectively).ConclusionThe state of attachment of the rotator cuff to the greater tuberosity might affect bone resorption at the greater tuberosity, such as the greater tuberosity after shoulder arthroplasty. In cases of shoulder arthroplasty for arthropathy with rotator cuff tear, performing rotator cuff repair might prevent bone resorption.Level of evidenceLevel IV; Prognosis Study 相似文献
8.
9.
This study evaluated the genetic variation of 17 autosomal short tandem repeat (STR) loci included in the PowerPlex® 18D Kit. Samples of 562 unrelated healthy Lahu individuals living in Yunnan Province in southwestern China were investigated. The data were analyzed to provide information on allele frequencies and other statistical parameters relevant to the forensic population. Of the 17 loci, 16 reached the Hardy–Weinberg equilibrium after Bonferroni correction. A total of 176 alleles were identified in 17 STR loci, and allele frequencies ranged from 0.000 890 to 0.578 292. The combined discrimination power (CPD) and probability of excluding paternity (CPE) of the 17 STR loci were 0.999 999 999 999 999 999 489 and 0.999 998 301 753 122. The genetic relationships among 28 populations were also estimated. 相似文献
10.
[摘要] 目的 探究HBV相关慢加急性肝衰竭(HBV-related acute-on-chronic liver failure, HBV-ACLF)患者血清中微小核糖核酸(microRNA, miR)-122和高迁移率族蛋白1(high-mobility group box-B1, HMGB1)水平及其与病情、预后的关系。方法 回顾性分析2016年1月—2018年1月我院收治的120例HBV-ACLF患者的一般及临床资料。根据临床结局,将患者分为存活组(53例)和死亡组(67例)。比较2组患者的一般资料、实验室检查指标及血清miR-122、HMGB1水平。多因素Logistic回归分析影响患者预后的因素。Pearson检验分析miR-122、HMGB1水平分别与TBIL、PA、终末期肝病评分模型(the model of end-stage liver disease score, MELD)评分的相关性。ROC曲线分析miR-122和HMGB1水平对患者的死亡预测价值,获得最佳临界值。根据临界值将患者分为A组、B组和C组,用Kaplan-Meier法绘制生存曲线,比较3组患者在3年随访期间的生存率。结果 存活组和死亡组患者的年龄、身体质量指数、并发症、病情分期、MELD评分、ALB、球蛋白、TBIL、ALT、AST、LDH、PT、PTA、HBV DNA、miR-122、HMGB1相比,差异均具有统计学意义(P均<0.05)。年龄、并发症、病情分期、MELD评分、TBIL、PT、PTA、miR-122、HMGB1均是影响患者预后的危险因素(P均<0.05)。miR-122、HMGB1水平分别与TBIL、MELD评分呈显著正相关,与PTA呈显著负相关(P均<0.05)。miR-122和HMGB1预测患者死亡的最佳临界值分别为31.42和14.56 μg/L。A组患者预后3年内生存率显著高于B组和C组(P均<0.05)。结论 miR-122和HMGB1水平与HBV-ACLF患者的病情和死亡预后密切相关,可间接反映患者的病情严重程度,在HBV-ACLF的诊断及预后中具有重要价值。 相似文献